Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · IEX Real-Time Price · USD
7.94
+0.24 (3.12%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Tango Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Cash & Equivalents
67.2460.54143.3128.3825.17
Short-Term Investments
270.5306.17342.51161.9417.54
Cash & Cash Equivalents
337.74366.7485.82190.3242.7
Cash Growth
-7.90%-24.52%155.27%345.67%-
Receivables
02220
Other Current Assets
8.86.574.521.31-1.05
Total Current Assets
346.54375.27492.34193.6341.66
Property, Plant & Equipment
53.4257.776.0911.311.83
Long-Term Investments
2.573.421.712.280
Other Long-Term Assets
0.050.010.020.042.28
Total Long-Term Assets
56.0361.27.8213.6214.11
Total Assets
402.57436.47500.16207.2555.76
Accounts Payable
2.794.453.231.840.67
Deferred Revenue
92.35123.88140.74152.7833.7
Current Debt
2.081.771.50.960.66
Other Current Liabilities
-51.28-74.56-104.78-114.67-9.17
Total Current Liabilities
45.9455.5540.6940.9225.85
Long-Term Debt
36.8439.3606.937.88
Other Long-Term Liabilities
66.6892.09114.72120.8114.12
Total Long-Term Liabilities
103.52131.45114.72127.7422.01
Total Liabilities
149.46186.99155.41168.6547.86
Total Debt
38.9241.131.57.888.54
Debt Growth
-5.38%2636.59%-80.94%-7.67%-
Retained Earnings
-371.26-269.51-161.34-103.1-51.13
Comprehensive Income
0.19-3.71-0.770.020.01
Shareholders' Equity
253.11249.48344.7538.6-47.8
Net Cash / Debt
298.82325.57484.32182.4434.17
Net Cash / Debt Growth
-8.22%-32.78%165.47%433.99%-
Net Cash Per Share
3.163.717.805.713.80
Working Capital
300.6319.73451.65152.7215.81
Book Value Per Share
2.682.845.551.21-5.32
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).